Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Graeme O'Connor
+44 7958543828
Graeme.O'Connor@gosh.nhs.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A study to monitor changes in body shape in children during treatment for leukaemia to identify if body fat increases the risk of poor response to chemotherapy

A study to monitor changes in body shape in children during treatment for leukaemia to identify if body fat increases the risk of poor response to chemotherapy

Recruiting

Open to: All Genders

Age: Child

Medical Conditions

Children with acute lymphoblastic leukaemia


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Acute lymphoblastic leukemia (ALL) is a type of blood cancer where the body produces too many immature white blood cells, leading to problems with healthy blood cell production. It commonly affects children and requires treatment like chemotherapy to target and eliminate the abnormal cells.

The purpose of this study is to investigate how treatment for acute lymphoblastic leukaemia (ALL) affects the nutritional health of children. We're planning the first big study that will track changes in body composition and how much energy the body uses at rest during the entire ALL treatment in kids. We also want to figure out when sarcopenic obesity, a condition where fat increases and muscle decreases, starts to happen, and when kids start changing their eating habits in a way that makes it worse. The data we collect could help doctors give better advice on diet and lifestyle to prevent problems related to sarcopenic obesity. It's important to note that being overweight or obese can increase the chances of ALL coming back, so understanding this is crucial.

So far, past studies have missed out on measuring these things properly in children with ALL. They either used old methods or didn't look at the full picture. We want to change that by using a reliable and non-invasive method called Bioelectrical Impedance Analysis (BIA) to measure body composition. BIA measures how electricity moves through different parts of the body to estimate things like fat and muscle. We also want to measure how much energy the body uses when it's at rest, which is a big part of how much energy we use every day.

Apart from treatment, we know that lifestyle factors, like sitting too much and not being active, can make kids gain weight. Sometimes, the treatment itself can make it harder to be active. So, we're also interested in looking at ways to encourage healthier habits in kids going through this treatment, especially when they're taking dexamethasone, a medicine that can affect their eating and activity.

However, previous reviews of studies haven't given us clear answers about what works best for helping these kids. We need more well-designed trials to figure out the best ways to manage their nutrition and lifestyle. This study aims to fill that gap and hopefully make life better for children with ALL.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 Feb 2024 31 Jan 2026

A DEXA scan is a type of X-ray that measures the structures within the bone. This can take up to 20mins
Bioelectrical-Impedance: measure muscle and fat level. It has 4 leads that are attached to your ankles and wrists and takes 10mins to collect information at baseline, 6 weeks, 6 months and 12 months
Indirect Calorimetry measures energy requirements by placing a space hood over the head to measure breathing and takes 10 minutes to collect information at baseline, 6 weeks, 6 months and 12 months


Children aged 6 -14 years with ALL.

You can take part if:



You may not be able to take part if:


1. 17 years old +2. Neuro-muscular disease


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Great Ormond Street Hospital
    Great Ormond Street
    London
    WC1N 3JH

There are no advantages at this early stage of the study but the results may provide insight and information to identify children who are at greater risk of developing sarcopenia during and after treatment and therefore ensure appropriate medical and dietetic intervention is accessed.
By monitoring and understanding when these changes occur throughout drug treatment, we hope to be able to reduce the development of sarcopenia, which will make the drugs work better and improve your child’s recovery.


The study is sponsored by Great Ormond Street Hospital for Children NHS Foundation Trust and funded by King Abdulaziz University.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN13488607
Last updated 15 May 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.